These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 16918471

  • 21. Cytochrome P450 networks in chemical space.
    Lee S, Kim D.
    Arch Pharm Res; 2010 Sep; 33(9):1361-74. PubMed ID: 20945135
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Chemical proteomic probes for profiling cytochrome p450 activities and drug interactions in vivo.
    Wright AT, Cravatt BF.
    Chem Biol; 2007 Sep; 14(9):1043-51. PubMed ID: 17884636
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Structural basis of selective cytochrome P450 inhibition.
    Halpert JR.
    Annu Rev Pharmacol Toxicol; 1995 Sep; 35():29-53. PubMed ID: 7598496
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Survey of Machine Learning Techniques for Prediction of the Isoform Specificity of Cytochrome P450 Substrates.
    Xiong Y, Qiao Y, Kihara D, Zhang HY, Zhu X, Wei DQ.
    Curr Drug Metab; 2019 May 22; 20(3):229-235. PubMed ID: 30338736
    [Abstract] [Full Text] [Related]

  • 33. Identification of novel substrates for human cytochrome P450 2J2.
    Lee CA, Neul D, Clouser-Roche A, Dalvie D, Wester MR, Jiang Y, Jones JP, Freiwald S, Zientek M, Totah RA.
    Drug Metab Dispos; 2010 Feb 22; 38(2):347-56. PubMed ID: 19923256
    [Abstract] [Full Text] [Related]

  • 34. WhichCyp: prediction of cytochromes P450 inhibition.
    Rostkowski M, Spjuth O, Rydberg P.
    Bioinformatics; 2013 Aug 15; 29(16):2051-2. PubMed ID: 23740742
    [Abstract] [Full Text] [Related]

  • 35. Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development.
    Zhou SF, Zhou ZW, Yang LP, Cai JP.
    Curr Med Chem; 2009 Aug 15; 16(27):3480-675. PubMed ID: 19515014
    [Abstract] [Full Text] [Related]

  • 36. Prediction of cytochrome P450 2B6-substrate interactions using pharmacophore ensemble/support vector machine (PhE/SVM) approach.
    Leong MK, Chen TH.
    Med Chem; 2008 Jul 15; 4(4):396-406. PubMed ID: 18673154
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Computational identification and binding analysis of orphan human cytochrome P450 4X1 enzyme with substrates.
    Kumar S.
    BMC Res Notes; 2015 Jan 17; 8():9. PubMed ID: 25595103
    [Abstract] [Full Text] [Related]

  • 39. From electrochemistry to enzyme kinetics of cytochrome P450.
    Shumyantseva VV, Kuzikov AV, Masamrekh RA, Bulko TV, Archakov AI.
    Biosens Bioelectron; 2018 Dec 15; 121():192-204. PubMed ID: 30218927
    [Abstract] [Full Text] [Related]

  • 40. Catalytic assays for human cytochrome P450: an introduction.
    Chang TK, Waxman DJ.
    Methods Mol Biol; 2006 Dec 15; 320():73-83. PubMed ID: 16719375
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.